Chemotherapeutic Drug Resistance Associated with Differential miRNA Expression of miR-375 and miR-27 among Oral Cancer Cell Lines
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24021244 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Kieran Caberto Huni und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Education in Orthodontic Dentistry, School of Dental Medicine, University of Nevada-Las Vegas, 1700 W. Charleston Boulevard, L…. Hauptthemen laut MEDLINE: MicroRNAs, Mouth Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Nevada, Las Vegas—School of Dental Medicine, Department of Advanced Education—Orthodontic Dental Residency Program.
Abstract (Originalsprache)
Recent advances have suggested that non-coding miRNAs (such as miR-21, miR-27, miR-145, miR-155, miR-365, miR-375 and miR-494) may be involved in multiple aspects of oral cancer chemotherapeutic responsiveness. This study evaluated whether these specific miRNAs are correlated with oral cancer responsiveness to chemotherapies, including Paclitaxel, Cisplatin and Fluorouracil (5FU). Commercially available and well-characterized oral squamous cell carcinoma cell lines (SCC4, SCC9, SCC15, SCC25 and CAL27) revealed differing resistance and chemosensitivity to these agents—with SCC9 and SCC25 demonstrating the most resistance to all chemotherapeutic agents. SCC9 and SCC25 were also the only cell lines that expressed miR-375, and were the only cell lines that did not express miR-27. In addition, the expression of miR-375 was associated with the upregulation of Rearranged L-myc fusion (RLF) and the downregulation of Centriolar protein B (POC1), whereas lack of miR-27 expression was associated with Nucleophosmin 1 (NPM1) expression. These data have revealed important regulatory pathways and mechanisms associated with oral cancer proliferation and resistance that must be explored in future studies of potential therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Advanced Education in Orthodontic Dentistry, School of Dental Medicine, University of Nevada-Las Vegas, 1700 W. Charleston Boulevard, Las Vegas, NV 89106, USA.
- Department of Clinical Sciences, School of Dental Medicine, University of Nevada-Las Vegas, 1700 W. Charleston Boulevard, Las Vegas, NV 89106, USA.
- Department of Biomedical Sciences, School of Dental Medicine, University of Nevada-Las Vegas, 1001 Shadow Lane, Las Vegas, NV 89106, USA.
ORCID-Profile: Katherine M Howard, Karl Kingsley
Förderung
- University of Nevada, Las Vegas—School of Dental Medicine
- Department of Advanced Education—Orthodontic Dental Residency Program
Zitieren
APA
Huni, K. C., Cheung, J., Sullivan, M., Robison, W. T., Howard, K. M., & Kingsley, K. (2023). Chemotherapeutic Drug Resistance Associated with Differential miRNA Expression of miR-375 and miR-27 among Oral Cancer Cell Lines. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021244
Vancouver
Huni KC, Cheung J, Sullivan M, Robison WT, Howard KM, Kingsley K. Chemotherapeutic Drug Resistance Associated with Differential miRNA Expression of miR-375 and miR-27 among Oral Cancer Cell Lines. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021244
BibTeX
@article{Huni2023,
author = {Huni, Kieran Caberto and Cheung, Jacky and Sullivan, Madeline and Robison, William Taylor and Howard, Katherine M and Kingsley, Karl},
title = {Chemotherapeutic Drug Resistance Associated with Differential miRNA Expression of miR-375 and miR-27 among Oral Cancer Cell Lines},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24021244}
}
EUVIMED